HomeCompareMDRA vs EQR

MDRA vs EQR: Dividend Comparison 2026

MDRA yields 9732.36% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDRA wins by $42205343452570096.00M in total portfolio value
10 years
MDRA
MDRA
● Live price
9732.36%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42205343452570096.00M
Annual income
$41,369,169,924,735,210,000,000.00
Full MDRA calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — MDRA vs EQR

📍 MDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDRAEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDRA + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDRA pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDRA
Annual income on $10K today (after 15% tax)
$827,250.61/yr
After 10yr DRIP, annual income (after tax)
$35,163,794,436,024,925,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, MDRA beats the other by $35,163,794,436,024,925,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDRA + EQR for your $10,000?

MDRA: 50%EQR: 50%
100% EQR50/50100% MDRA
Portfolio after 10yr
$21102671726285048.00M
Annual income
$20,684,584,962,367,605,000,000.00/yr
Blended yield
98.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MDRA
No analyst data
Altman Z
-63.4
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDRA buys
0
EQR buys
0
No recent congressional trades found for MDRA or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDRAEQR
Forward yield9732.36%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$42205343452570096.00M$47.8K
Annual income after 10y$41,369,169,924,735,210,000,000.00$5,475.61
Total dividends collected$42149677066811080.00M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MDRA vs EQR ($10,000, DRIP)

YearMDRA PortfolioMDRA Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$983,936$973,236.01$11,380$679.82+$972.6KMDRA
2$90,548,321$89,495,509.90$13,014$837.25+$90.54MMDRA
3$7,794,055,630$7,697,168,926.38$14,961$1,036.20+$7794.04MMDRA
4$627,538,769,782$619,199,130,257.48$17,297$1,289.22+$627538.75MMDRA
5$47,264,782,575,230$46,593,316,091,563.77$20,121$1,613.15+$47264782.56MMDRA
6$3,330,294,655,792,460$3,279,721,338,436,963.00$23,561$2,030.84+$3330294655.77MMDRA
7$219,535,770,211,624,400$215,972,354,929,926,430.00$27,783$2,573.54+$219535770211.60MMDRA
8$13,540,581,545,048,480,000$13,305,678,270,922,040,000.00$33,013$3,284.39+$13540581545048.45MMDRA
9$781,470,586,761,576,300,000$766,982,164,508,374,600,000.00$39,547$4,223.51+$781470586761576.38MMDRA
10$42,205,343,452,570,094,000,000$41,369,169,924,735,210,000,000.00$47,791$5,475.61+$42205343452570096.00MMDRA

MDRA vs EQR: Complete Analysis 2026

MDRAStock

Medra Corporation engages in the acquisition, development, and commercial exploitation of hydrogen-based technologies. The company primarily concentrates on fuel cells, hydrogen-specific sensors, and hydrogen safety. It seeks out technologies, secures those technologies through licensing agreements with the patent holders, and converts the technologies into viable products that it then produces and sells. DCH manufactures and sells a line of hydrogen sensors that are both mobile (a hand held unit) and stationary (wall ceiling or conduit mounted units) to a range of industries and customers. The company also develops, manufactures, and sells fuel cells that range from 12 watts to five kilo watts. Its H2SCAN hydrogen-specific sensing systems offer an alternative to gas detectors used in various industries, including food processing, petrochemical production, semiconductor manufacturing, and glass and metals processing. The company has licenses to various technologies, including The Robust Hydrogen Sensor, The Thick Film Hydrogen Sensor, and The Proton Exchange Membrane Fuel Cell. Medra Corporation was founded in 1994 and is based in Valencia, California.

Full MDRA Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this MDRA vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDRA vs SCHDMDRA vs JEPIMDRA vs OMDRA vs KOMDRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.